MarketInOut Stock Screener Log In | Sign Up

Bionime Corp

TAI • Healthcare • Medical Instruments & Supplies • Quote as of 10/30/2026
Bionime Corp stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeTAI
Market Capitalization4,629.39 mln
Float62.70 mln

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.74
Likely reliable

Relative Strength

99 / 100
Top performer

Debt / Equity

1.26
Elevated leverage

Pre-Tax Margin

-22%
Deeply loss-making

ROE

-14.64
Negative

Business Description

Founded in 2003 and headquartered in Taichung, Taiwan, Bionime Corporation develops and sells blood sugar monitoring products, including meters, test strips, and continuous glucose monitoring systems, marketed under the RIGHTEST and iFree CGM brands. The company serves pharmacies, hospitals, and medical equipment distributors across markets in Asia, Europe, North America, and beyond. Bionime also provides pharmaceutical testing, biotechnology services, and precision instrument sales.

Key Fundamentals

EPS-4.02
ROE-14.64
RPS24.09
ROIC-4.24
ROA-5.07
Interest Cover236
EBITDA, mln-135
EV / EBITDA-48.29
EV / EBIT-20.70
Revenue, mln1,717
EV / Revenue3.79

Quote Details

Last 65.60
Change 5.3 (8.79%)
Open 60.60
Volume 453,668
Turnover 29,760,620
Average Volume 70,062

Financial Ratios

Pre-Tax Profit Margin-22
Leverage Ratio2.69
Current Ratio0.77
Price / Book2.03
Price / Tangible Book3.60
Price / Cash Flow37.34
Price / Free Cash Flow99.64
Debt / Equity1.26
Price / Sales2.30

Financial Strength

Altman Z-Score0.72
Piotroski F-Score 3 / 9
Beneish M-Score-2.74
Price to Intrinsic Value2.31
Shiller PE Ratio68.29

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 15.09% 99 / 100   
1 Month 16.52% 98 / 100   
2 Months 17.56% 89 / 100   
6 Months 9.33% 67 / 100   
1 Year 2.5% 48 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog